Sign in

CIK 0000318306

  • Non-accelerated filer
  • Smaller reporting company

ABEONA THERAPEUTICS INC.

Sign in to watch
Ticker
ABEO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
830221517
Phone
+1 646-813-4701
Business address
6555 CARNEGIE AVE, 4TH FLOOR, CLEVELAND, OH, 44103
Former names
PLASMATECH BIOPHARMACEUTICALS INC, ACCESS PHARMACEUTICALS INC, CHEMEX PHARMACEUTICALS INC
  1. 4 Open-market sale Director sold 20,000 shares at $0.15 ($3,098)
  2. 4 Shares withheld for taxes Chief Executive Officer gave up 81,525 shares (to pay taxes)
  3. 4 Open-market sale Director sold 35,000 shares at $0.16 ($5,464)
  4. 4 Grant or award Chief Financial Officer acquired 200,000 shares (grant or award)
  5. 3 Insider Initial Statement of Ownership
  6. 4 Open-market sale SVP, General Counsel sold 8,880 shares at $0.57 ($5,035)
  7. 4 Open-market sale SVP, General Counsel sold 8,880 shares at $0.89 ($7,894)
  8. 4 Grant or award Chief Executive Officer acquired 50,000 shares (grant or award)
  9. 4 Open-market sale SVP, General Counsel sold 25,734 shares at $0.90 ($23,271)
  10. 4 Open-market sale Director sold 25,000 shares at $0.97 ($24,150)
  11. 4 Open-market sale SVP, General Counsel sold 25,210 shares at an average $1.05 ($26,484)
  12. 4 Open-market sale Chief Financial Officer sold 29,122 shares at $1.05 ($30,596)
  13. 4 Open-market sale Chief Executive Officer sold 45,409 shares at $1.09 ($49,382)
  14. 4 Grant or award SVP, General Counsel acquired 136,000 shares (grant or award)
  15. 3 Insider Initial Statement of Ownership
  16. 4 Grant or award Chief Financial Officer acquired 238,000 shares (grant or award)
  17. 4 Grant or award SVP, Head of Res./Clin. Dev. acquired 300,000 shares (grant or award)
  18. 3 Insider Initial Statement of Ownership
  19. 4 Grant or award Director acquired 77,181 shares (grant or award)
  20. 4 Grant or award Director acquired 38,590 shares (grant or award)

Page 10 of 20 · 394 filings